These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29122712)

  • 61. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
    Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs.
    Dong Y; Feng SS
    Biomaterials; 2005 Oct; 26(30):6068-76. PubMed ID: 15894372
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.
    Ocal H; Arica-Yegin B; Vural I; Goracinova K; Caliş S
    Drug Dev Ind Pharm; 2014 Apr; 40(4):560-7. PubMed ID: 23596973
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma.
    Salama HA; Ghorab M; Mahmoud AA; Abdel Hady M
    AAPS PharmSciTech; 2017 Oct; 18(7):2517-2528. PubMed ID: 28224390
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preparation, characterization and in vivo evaluation of a combination delivery system based on hyaluronic acid/jeffamine hydrogel loaded with PHBV/PLGA blend nanoparticles for prolonged delivery of Teriparatide.
    Bahari Javan N; Montazeri H; Rezaie Shirmard L; Jafary Omid N; Barbari GR; Amini M; Ghahremani MH; Rafiee-Tehrani M; Abedin Dorkoosh F
    Eur J Pharm Sci; 2017 Apr; 101():167-181. PubMed ID: 28193537
    [TBL] [Abstract][Full Text] [Related]  

  • 68. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.
    Chan JM; Zhang L; Yuet KP; Liao G; Rhee JW; Langer R; Farokhzad OC
    Biomaterials; 2009 Mar; 30(8):1627-34. PubMed ID: 19111339
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods.
    Arasoglu T; Derman S; Mansuroglu B
    Nanotechnology; 2016 Jan; 27(2):025103. PubMed ID: 26629915
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
    Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
    J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
    [TBL] [Abstract][Full Text] [Related]  

  • 71. PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen.
    Lozoya-Agullo I; Araújo F; González-Álvarez I; Merino-Sanjuán M; González-Álvarez M; Bermejo M; Sarmento B
    Eur J Pharm Sci; 2018 Mar; 115():119-125. PubMed ID: 29248559
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Using PVA and TPGS as combined emulsifier in nanoprecipitation method improves characteristics and anticancer activity of ibuprofen loaded PLGA nanoparticles.
    Sahin A; Spiroux F; Guedon I; Arslan FB; Sarcan ET; Ozkan T; Colak N; Yuksel S; Ozdemir S; Ozdemir B; Akbas S; Ultav G; Aktas Y; Capan Y
    Pharmazie; 2017 Sep; 72(9):525-528. PubMed ID: 29441979
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Indocyanine green-loaded biodegradable nanoparticles: preparation, physicochemical characterization and in vitro release.
    Saxena V; Sadoqi M; Shao J
    Int J Pharm; 2004 Jul; 278(2):293-301. PubMed ID: 15196634
    [TBL] [Abstract][Full Text] [Related]  

  • 74. PLGA nanoparticles for intravitreal peptide delivery: statistical optimization, characterization and toxicity evaluation.
    Bisht R; Rupenthal ID
    Pharm Dev Technol; 2018 Apr; 23(4):324-333. PubMed ID: 27670289
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Development and optimization of methotrexate-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery applications.
    Tahir N; Madni A; Balasubramanian V; Rehman M; Correia A; Kashif PM; Mäkilä E; Salonen J; Santos HA
    Int J Pharm; 2017 Nov; 533(1):156-168. PubMed ID: 28963013
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms.
    Xie X; Tao Q; Zou Y; Zhang F; Guo M; Wang Y; Wang H; Zhou Q; Yu S
    J Agric Food Chem; 2011 Sep; 59(17):9280-9. PubMed ID: 21797282
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Development of bicalutamide-loaded PLGA nanoparticles: preparation, characterization and in-vitro evaluation for the treatment of prostate cancer.
    Ray S; Ghosh Ray S; Mandal S
    Artif Cells Nanomed Biotechnol; 2017 Aug; 45(5):944-954. PubMed ID: 27327352
    [TBL] [Abstract][Full Text] [Related]  

  • 78. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
    Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
    Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Investigation and optimization of formulation parameters on preparation of targeted anti-CD205 tailored PLGA nanoparticles.
    Jahan ST; Haddadi A
    Int J Nanomedicine; 2015; 10():7371-84. PubMed ID: 26677326
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption.
    Hanna LA; Basalious EB; ELGazayerly ON
    Drug Deliv; 2016 Nov; 24(1):188-198. PubMed ID: 28156176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.